Is Postpartum Depression Different From Depression Occurring Outside of the Perinatal Period? A Review of the Evidence
- PMID: 33162848
- PMCID: PMC7587887
- DOI: 10.1176/appi.focus.20190045
Is Postpartum Depression Different From Depression Occurring Outside of the Perinatal Period? A Review of the Evidence
Abstract
Whether a major depressive episode occurring in the postpartum period (i.e., postpartum depression [PPD]) is sufficiently distinct from major depressive episodes occurring at other times (i.e., major depressive disorder) to warrant a separate diagnosis is a point of debate with substantial clinical significance. The evidence for and against diagnostic distinction for PPD is reviewed with respect to epidemiology, etiology, and treatment. Overall, evidence that PPD is distinct from major depressive disorder is mixed and is largely affected by how the postpartum period is defined. For depression occurring in the early postpartum period (variably defined, but typically with onset in the first 8 weeks), symptom severity, heritability, and epigenetic data suggest that PPD may be distinct, whereas depression occurring in the later postpartum period may be more similar to major depressive disorder occurring outside of the perinatal period. The clinical significance of this debate is considerable given that PPD, the most common complication of childbirth, is associated with immediate and enduring adverse effects on maternal and offspring morbidity and mortality. Future research investigating the distinctiveness of PPD from major depressive disorder in general should focus on the early postpartum period when the rapid decline in hormones contributes to a withdrawal state, requiring profound adjustments in central nervous system function.
Keywords: epidemiology; etiology; major depressive disorder; postpartum depression; treatment.
Copyright © by the American Psychiatric Association.
Conflict of interest statement
Dr. Epperson reports that she consults to Sage Therapeutics and serves on the advisory board of Asarina Pharma. She has investments in Abbott, Abbvie, Johnson and Johnson, Merck, and Pfizer. The other authors report no financial relationships with commercial interests.
References
-
- Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA, American Psychiatric Publishing , 2013
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources